Barbara Davis Center for Diabetes, Aurora, CO [email protected]
Dr. Akturk reports receiving consulting fees from the American Diabetes Association, grants from REMD Biotherapeutics, Eli Lilly, Dexcom, Senseonics, and IM Therapeutics, grants and consulting fees from Mannkind, and consulting fees from Sanofi; and Dr. Shah, receiving grants and consulting fees from Sanofi and Dexcom and grants from JDRF, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, vTv Therapeutics, Mylan, Eli Lilly, NovoNordisk, and Insulet. No other potential conflict of interest relevant to this letter was reported.